Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study

Overview of attention for article published in BMC Neurology, January 2017

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 100 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 27,088 followers.

RT @hichachu: Long-term efficacy and safety of fingolimod in Japanese patients with relapsing MS https://t.co/YGjH9UX3Xr #wcn17 Japan-made,…

Reply Repost Favourite

Long-term efficacy and safety of fingolimod in Japanese patients with relapsing MS https://t.co/YGjH9UX3Xr #wcn17 Japan-made,MRI-typical MS

Reply Repost Favourite

Continuous fingolimod treatment over 36 months may provide long term benefit for patients with #multiplesclerosis https://t.co/yFP8vM5yYM

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.